BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2019
View Archived Issues
Coming up for air
Read More
Vaxart initiates bivalent norovirus vaccine phase Ib study
Read More
Engineered protein can block "undruggable" oncogene
Read More
Alexion and Zealand Pharma collaborate to discover and develop novel peptide therapies
Read More
SOX2OT as a novel prognostic biomarker in bladder cancer
Read More
SIRS and hypoxemia in acute pancreatitis could be patient selection factors in studies of CM-4620
Read More
HSJ-633 prevents inflammation-induced preterm birth and fetal tissue injury in vivo
Read More
Aptevo initiates dosing in phase I study of APVO-210
Read More
Cancer gene therapy VB-111 has immunotherapeutic effects in resistant ovarian cancer
Read More
Ovarian cancer vaccine DCVAC/OvCa significantly improves survival in phase II trial
Read More
Hexima reports findings from second part of phase I/IIa onychomycosis study of HXP-124
Read More
Innovent initiates Chinese phase IIa study of IBI-306 for hypercholesterolemia
Read More
Knopp Biosciences enters collaboration to initiate phase II trial of dexpramipexole
Read More
Hangzhou Pulve Biotechnology describes chimeric antigen receptors targeting mesothelin
Read More
Chinese Academy of Sciences patents collagen-targeting VEGF
Read More
Merck & Co. identifies adenosine A2A and/or A2B receptor antagonists
Read More
Protein disulfide-isomerase inhibitors discovered at MUSC Foundation for Research Development
Read More
Genzada initiates phase I trial of GZ17-6.02 in advanced solid tumors and lymphoma
Read More
Vivace Therapeutics presents YAP1/TEAD interaction inhibitors
Read More
FDA approves Sunosi for excessive daytime sleepiness associated with narcolepsy or OSA
Read More
Genenta intiates phase I/II studies of Temferon in glioblastoma and multiple myeloma
Read More
First patient dosed in phase II RAIN-701 study of tarloxotinib in NSCLC
Read More
NapaJen, Astellas enter collaboration for development of novel oligonucleotides
Read More
Phase III ENGAGE and EMERGE studies of aducanumab in Alzheimer's to end based on futility analysis
Read More
Enterome announces collaboration with Dana-Farber on microbiome-derived cancer immunotherapy
Read More